The Science Behind Alcolim

Clinical studies have revealed that one of the main reasons for excessive alcohol intake by some people is rooted in a profound imbalanced functioning of their cerebral cortex. In particular, the frontal cortex is directly associated with our ability to control behaviour and actions.

The Science of Alcolim

Clinical studies have revealed that one of the main reasons for excessive alcohol intake by some people is rooted in a profound imbalanced functioning of their cerebral cortex. In particular, the frontal cortex is directly associated with our ability to control behaviour and actions. Therefore if the frontal cortex is abnormally functioning, this can lead to a decreased ability of an individual to control alcohol intake.

Alcolim has been developed to normalise the activity of the cerebral cortex of the brain.

Alcolim is highly bio-available to ensure it is quickly taken up by the brain where all components synergistically exert their pharmacological effects restoring balance and normal function to the cerebral cortex.

Alcolim contains: Pyruvate, Ascorbic Acid, Magnesium Oxide, Lactic Acid and Chromium Glutonate.


Pyruvate is derived from glucose. It is metabolised in the liver and modulates the signals which the liver sends to the brain relating to the metabolic status of the body. From clinical studies pyruvate, in specific concentrations, is thought to act on the hypothalamus to increase serotonin levels which inhibits the intake of carbohydrate-based food / drink, whilst decreasing noradrenaline which stimulates their intake. This results in a reduced craving for carbohydrate based food and drink. As Alcohol is largely carbohydrate based, this results in a reduced craving of alcohol. Because Pyruvate also has an anti-stress effect this may also help relieve cravings for alcohol when connected to stressful situations.


Ascorbic acid helps protect the brain from oxidative stress (excessive formation of damaging free radicals). It can also help reduce the toxic effects of alcohol. Higher levels of Ascorbic acid in the brain than are generally found in the body are required to achieve this protection. In addition it modulates the neurotransmitters in the brain.


In the brain, too much Ascorbic acid inhibits the ability of magnesium to create the right environment both in the brain fluid and in brain cells for neurons to thrive and communicate. Too much magnesium will reduce neuron activity acting much like a natural tranquiliser. For healthy neuron activity to take place, magnesium must be allowed to do its job. However if there is too much Ascorbic acid, this also affects the ability of Magnesium to work efficiently and creates an imbalance. Magnesium Oxide has been added to Alcolim to balance the extra/intracellular ion levels.


Pyruvate can be converted into Lactic Acid by the enzyme lactic acid dehydrongenase. Therefore to ensure that the pyruvate remains stable, Lactic acid is added in very specific quantities to help prevent the pyruvate from transforming back into lactic acid. As a secondary effect lactic acid will also help eliminate toxic acid substances from both the brain and the liver tissue that have accumulated during chronic alcohol abuse.


Chromium is essential for maintaining normal glucose metabolism and utilisation. Chromium assists insulin to transport glucose into a cell and also it is involved in the utilisation of sugar for conversion into energy in a cellThe importance of chromium is based on its vital role in the activities of several enzymes.

Chromium levels in the body tissues deplete as we age, particularly in the brain and liver. The consequences of a decreased level of chromium are associated not only with impaired glucose utilisation but also with the decreased production of some lipids (fatty substances such as cholesterol, cerebrosides, etc.) which are essential for the normal functioning of the cerebral cortex and the brain in general.

Chromium gluconate has been added to Alcolim to increase the production of myelin and components of the nervous cell membranes which become damaged during any chronic consumption of excessive quantities of alcohol. In addition it will improve the utilisation of glucose by the brain which is vital for the production and the activity of some neurotransmitters, such as gamma-aminobutyric acid. This is one of the key neurotransmitters and it is profoundly depleted in people suffering from alcohol abuse.

Alcolim is formulated by Dr Galkina-Taylor, who spent 28 years working in various institutions controlled by The Russian Academy of Science and Medical Sciences. Her work has gained international recognition by some of the world’s leading medical establishments.

Dr Galkina-Taylor’s professional qualifications include:
Member of the Royal Society of Chemistry (
Fellow of the Institute of Biomedical Science (
Member of the New York Academy of Sciences (
Member of the American Chemical Society (
Recognition by the Health Professional Council as a Biomedical Scientist (


1. Green, J. M. (1989). Basic Clinical Physiology, 3rd Edition. Oxford University Press.

2. Goldstein, J. A. (1996). Betrayal by the Brain: The Neurologic Basis of Chronic Fatigue Syndrome, Fibromyalgia Syndrome, and Related Neural Network Disorders. The Haworth Medical Press Inc., NY.

3. New Guide to Medicine and Drugs, 6th Edition (2004). Henry, J. A. (Chief medical ed.). The British Medical Association.

4. Langhams, W., Damaske, U. and Scharrer, D. (1985). Different metabolites might reduce food intake by the mitochondrial generation of reducing equivalents. Appetite, 6:143-152.

5. Langhams, W., Pantel, K. and Scharrer, D. (1985). Selective hepatic vagotomy eliminates the hypophagic effect of different metabolites. J. Auton. Nerv. Syst., 13:255-262.

6. Pharmacological Basis of Therapeutics, 9th Edition (1996). Molinoff, P. B. and Ruddon, R. W. (Eds.) McGraw-Hill Book Company.

7. Illustrated Medical Dictionary (2007). Peters, M. (Consulting medical ed.). The British Medical Association.

8. Snor-Posner, G., Grinker, Y. A., Marinescu, C. et al. (1986). Hypothalamic serotonin in the control of meal patterns and macronutrient selection. Brain Res. Bull., 17:663-671.

9. Stanley, B.G., Daniel, D. R., Chim, A. S. et al. (1985). Paraventricular nucleus injection of peptide YY and neuropeptide Y preferentially enhance carbohydrate ingestion. Peptid, 6:1205-1211.

10. Thomson, A. D. and Cotton, R. E. (1983). Lecture Notes on Pathology, 3rd edition. Blackwell Scientific Publications.

11. White, A., Hadler, P. and Smith, E. (1968). Principles of Biochemistry, 4th edition. Library of Congress Catalog Card Number: 67-26890. McGraw-Hill Book Company and Kōyakusha Ltd.